CORC  > 上海药物研究所  > 中国科学院上海药物研究所
Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2
Liao, Xiao-ying2; Deng, Qiang-qiang3; Han, Li1,3; Wu, Zhi-tao3; Peng, Zhao-liang3; Xie, Yuan2; Wang, Guang-ji2; Aa, Ji-ye2; Pan, Guo-yu1,3
刊名ACTA PHARMACOLOGICA SINICA
2020
卷号41期号:1页码:129-137
关键词leflunomide teriflunomide acyclovir organic anion transporter multidrug resistance associated protein (MRP) 2 drug-drug interaction pharmacokinetics
ISSN号1671-4083
DOI10.1038/s41401-019-0283-z
通讯作者Aa, Ji-ye(jiyea@cpu.edu.cn) ; Pan, Guo-yu(gypan@simm.ac.cn)
英文摘要Rheumatoid arthritis patients can be prescribed a combination of immunosuppressive drug leflunomide (LEF) and the antiviral drug acyclovir to reduce the high risk of infection. Acyclovir is a substrate of organic anion transporter (OAT) 1/3 and multidrug resistance-associated protein (MRP) 2. Considering the extraordinarily long half-life of LEF's active metabolite teriflunomide (TER) and the kidney injury risk of acyclovir, it is necessary to elucidate the potential impact of LEF on the disposition of acyclovir. Here we used a specific MRP inhibitor MK571 and probenecid (OAT1/3 and MRP2 inhibitor) to assess the effects of MRP2 and OAT1/3 on the pharmacokinetics and tissue distribution of acyclovir in rats. We showed that LEF and probenecid, but not MK571 significantly increased the plasma concentration of acyclovir. However, kidney and liver exposures of acyclovir were increased when coadministered with LEF, probenecid or MK571. The kidney/plasma ratio of acyclovir was increased to approximately 2-fold by LEF or probenecid, whereas it was increased to as much as 14.5-fold by MK571. Consistently, these drugs markedly decreased the urinary excretion of acyclovir. TER (0.5-100 mu mol/L) dose-dependently increased the accumulation of acyclovir in MRP2-MDCK cells with an IC50 value of 4.91 mu mol/L. TER (5 mu mol/L) significantly inhibited the uptake of acyclovir in hOAT1/3-HEK293 cells. These results suggest that LEF/TER increased the kidney accumulation of acyclovir by inhibiting the efflux transporter MRP2, which increased its kidney/plasma ratio and renal injury risk. However, the inhibitory effects of LEF/TER on OAT1/3 reduced the tubular cells' uptake of acyclovir and increased the plasma concentration.
资助项目Organ Reconstruction and Manufacturing Strategic Priority Research Program of the Chinese Academy of Sciences[XDA16020205] ; National Natural Science Foundation of China[81872927] ; National Key Special Project of Science and Technology for Innovation Drugs of China[2015zx09501001] ; Independent Deployment Program of the Institute of Pharmaceutical Innovation of the Chinese Academy of Sciences[CASIMM0120184005]
WOS关键词NONSTEROIDAL ANTIINFLAMMATORY DRUGS ; ORGANIC ANION TRANSPORTERS ; INTRAVENOUS ACYCLOVIR ; RHEUMATOID-ARTHRITIS ; ANTIVIRAL RESISTANCE ; METABOLITE A771726 ; PHARMACOKINETICS ; METHOTREXATE ; ZOSTER ; RISK
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
出版者NATURE PUBLISHING GROUP
WOS记录号WOS:000505540800014
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/282359]  
专题中国科学院上海药物研究所
通讯作者Aa, Ji-ye; Pan, Guo-yu
作者单位1.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
2.China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Liao, Xiao-ying,Deng, Qiang-qiang,Han, Li,et al. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2[J]. ACTA PHARMACOLOGICA SINICA,2020,41(1):129-137.
APA Liao, Xiao-ying.,Deng, Qiang-qiang.,Han, Li.,Wu, Zhi-tao.,Peng, Zhao-liang.,...&Pan, Guo-yu.(2020).Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.ACTA PHARMACOLOGICA SINICA,41(1),129-137.
MLA Liao, Xiao-ying,et al."Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2".ACTA PHARMACOLOGICA SINICA 41.1(2020):129-137.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace